GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sensus Healthcare Inc (NAS:SRTS) » Definitions » Cash Ratio

Sensus Healthcare (Sensus Healthcare) Cash Ratio : 5.50 (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Sensus Healthcare Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Sensus Healthcare's Cash Ratio for the quarter that ended in Dec. 2023 was 5.50.

Sensus Healthcare has a Cash Ratio of 5.50. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Sensus Healthcare's Cash Ratio or its related term are showing as below:

SRTS' s Cash Ratio Range Over the Past 10 Years
Min: 1.38   Med: 2.49   Max: 5.5
Current: 5.5

During the past 11 years, Sensus Healthcare's highest Cash Ratio was 5.50. The lowest was 1.38. And the median was 2.49.

SRTS's Cash Ratio is ranked better than
84.8% of 855 companies
in the Medical Devices & Instruments industry
Industry Median: 1.23 vs SRTS: 5.50

Sensus Healthcare Cash Ratio Historical Data

The historical data trend for Sensus Healthcare's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sensus Healthcare Cash Ratio Chart

Sensus Healthcare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.39 3.07 2.43 3.32 5.50

Sensus Healthcare Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.32 3.14 3.86 3.92 5.50

Competitive Comparison of Sensus Healthcare's Cash Ratio

For the Medical Devices subindustry, Sensus Healthcare's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sensus Healthcare's Cash Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sensus Healthcare's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Sensus Healthcare's Cash Ratio falls into.



Sensus Healthcare Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Sensus Healthcare's Cash Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash Ratio (A: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=23.148/4.212
=5.50

Sensus Healthcare's Cash Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash Ratio (Q: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=23.148/4.212
=5.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sensus Healthcare  (NAS:SRTS) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Sensus Healthcare Cash Ratio Related Terms

Thank you for viewing the detailed overview of Sensus Healthcare's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sensus Healthcare (Sensus Healthcare) Business Description

Traded in Other Exchanges
Address
851 Broken Sound Parkway, NW, Suite 215, Boca Raton, FL, USA, 33487
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating skin cancers including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
Executives
Joseph C Sardano director, officer: Chief Executive Officer 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Michael Sardano officer: GENERAL COUNSEL 851 BROKEN SOUND PARKWAY NW STE. 215, BOCA RATON FL 33487
John Heinrich director 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Samuel O'rear director 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Magdalena Martinez officer: Chief Operating Officer 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Emiliano Sosa officer: Chief Technology Officer 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
William H Mccall director 851 BROKEN SOUND PARKWAY NW STE. 215, BOCA RATON FL 33487
Nicolas Soro officer: Chief Operating Officer 851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487
Javier Rampolla officer: Chief Financial Officer 851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487
Stephen Brad Cohen officer: EXECUTIVE VICE PRESIDENT 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Megan Cornish director 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Yonatan Vainer officer: Chief Technology Officer 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Russ Price officer: Chief Technology Officer 851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487
Kalman Fishman officer: CHIEF TECHNOLOGY OFFICER 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Richard Golin officer: EXECUTIVE VICE PRESIDENT 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487